Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults-Reference-Cited by-同舟云学术

Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults

Published:2017-05-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Onwumeh Jennifer¹,Okwundu Charles I²³,Kredo Tamara³

Affiliation:

1. Faculty of Health Sciences, Stellenbosch University; Community Health Division; Cape Town South Africa 7505

2. Stellenbosch University; Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences; Francie van Zijl Drive Tygerberg Cape Town South Africa 7505

3. South African Medical Research Council; Cochrane South Africa; PO Box 19070 Cape Town South Africa

Publisher

Wiley

Subject

Pharmacology (medical)

Reference51 articles.

1. Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059;Abrams;Journal of Acquired Immune Deficiency Syndromes,2002

2. The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT;Abrams;Controlled Clinical Trials,2002

3. Interleukin-2 therapy in patients with HIV infection;Abrams;New England Journal of Medicine,2009

4. Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration. Irhan Study Group;Amendola;Clinical and Experimental Immunology,2000

5. Different rates of CD41 and CD81 T-cell proliferationin interleukin-2-treated human immunodeficiency virus-positive subjects;Caggiari;Cytometry (Communications in Clinical Cytometry),2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy;Journal of Drug Targeting;2024-05-27

2. Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir;Frontiers in Immunology;2024-01-05

3. Immunological inefficiency of art in HIV-infected patients;HIV Infection and Immunosuppressive Disorders;2023-07-20

4. 175 Years of Bilirubin Testing: Ready for Point‐of‐Care?;Advanced Healthcare Materials;2023-04-10

5. Host-directed immunotherapy of viral and bacterial infections: past, present and future;Nature Reviews Immunology;2022-06-07